Home > Healthcare > Medical Devices > Medical Supplies > micropump market
Get a free sample of Micropump Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Micropump Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Micropump Market size surpassed USD 1.5 billion in 2021 and is projected to depict over 19.5% CAGR from 2022 to 2030. The integration of advanced technologies in micropump devices is among the leading factors positively influencing the industry outlook.
Key market players have lately been upgrading conventional micropumps, such as rotary vanes, diaphragm pumps, lab-on-chip, ion-driven air flow micropump, etc., to increase their precision and accuracy. The increasing focus on developing cutting-edge medical devices with improved capabilities will transform the market dynamics.
The patient-friendly, compact infusion pump is used for continuous subcutaneous drug administration to treat patients with Parkinson’s disease and is available in several European countries. Implantable devices involve several risks and post-procedural complications, such as implant failure, infection, swelling, pain, redness, and pain at the surgical site, factors such as these are projected to negatively impact product adoption.
The medical device segment is anticipated to depict over 20.5% growth rate from 2022 to 2030, attributed to the mounting demand for lightweight and concise medical devices due to their enhanced portability and ease of use.
Global market size for micropump was worth more than USD 1.5 billion in 2021 and is anticipated to exhibit over 19.5% CAGR from 2022 to 2030 backed by the rapid integration of advanced technologies in conventional micropumps.
Mechanical micropump segment accounted for over USD 1 billion in 2021 and is projected to garner appreciable revenues by 2030 due to the broad range of applications of mechanical micropumps, including targeted medicine administration, microprocessor cooling, and fuel injection.
Prominent players in the micropump market are Xavitech Micropumps, Sensile Medical (Gerresheimer AG), Antylia Scientific, Idex Corporation, Dolomite Microfluids (Blacktrace Holdings Ltd.), The Lee Company, Thomas Gardner Denver (Ingersoll Rand), Takasago Electric, Inc., Servoflo Corporation, and Bio-chem Fluidics (Halma).